Treatment Outcomes of Older Participants in a Randomized Trial Comparing Two Schedules of Twice-Daily Thoracic Radiotherapy in Limited-Stage SCLC

202311 citationsJournal Articlehybrid Open Access

Authors

Kristin Toftaker Killingberg · Norwegian University of Science and Technology

Bjørn Henning Grønberg · Norwegian University of Science and Technology

Øyvind Kirkevold · Norwegian University of Science and Technology

Tarje Onsøien Halvorsen · Norwegian University of Science and Technology

Abstract

Patients above or equal to 70 years old tolerated concurrent twice-daily chemoradiotherapy and achieved similar disease control as younger patients, indicating older patients should receive the same treatment as younger patients.

Topics & Keywords

Lung Cancer Research Studies Neutropenia and Cancer Infections Neuroendocrine Tumor Research Advances

Publication Details

Published in: Journal of Thoracic Oncology

Volume 18, Issue 6, pp. 803-812

DOI: 10.1016/j.jtho.2023.01.012

Field-Weighted Citation Impact: 2.52

Command Palette

Treatment Outcomes of Older Participants in a Randomized Trial Comparing Two Schedules of Twice-Daily Thoracic Radiotherapy in Limited-Stage SCLC

Authors

Abstract

Topics & Keywords

Publication Details